Action MBOT MICROBOT MEDICAL INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Microbot Medical Inc.

Actions

MBOT

US59503A2042

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
1,095 USD 0,00 % Graphique intraday de Microbot Medical Inc. +1,39 % -33,23 %
08/07 Microbot Medical enrôle le premier patient dans l'essai clinique humain du système chirurgical Liberty MT
08/07 Microbot Medical a recruté le premier patient de son essai clinique pivot chez l'homme CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial
Microbot Medical Signs Clinical Trial Deal With Baptist Hospital of Miami
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Inc Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Inc. announced that it has received $1.762502 million in funding
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
Microbot Medical Files Common Stock Registration Statement
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Sector Update: Health Care Stocks Gain Late Afternoon
Microbot Gets FDA Nod to Start Trial, to Raise $2.35 Million From Direct Offering Deal; Shares Soar
Top Midday Gainers
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
Microbot Medical Inc. Has Received FDA Approval to Proceed with Its Pivotal Human Clinical Trial
Microbot Medical Inc. announced that it expects to receive $1.762502 million in funding
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MBOT
  4. Actualités Microbot Medical Inc.
  5. Autres langues